ABT Earnings

ABT reported its earnings on 2026-04-16, showcasing a revenue of 11.16B against an estimate of 11.02B, resulting in a 1.31% surprise. The EPS was 1.15, surpassing the expected 1.14 by 0.88%. The stock experienced a -6% price change on the earnings day and a -8.7% change over the next five days, reflecting market reactions to the results.

Following ABT's earnings announcement on 2026-04-16, the stock price moved by -6% on the day of the release. Over the subsequent five days, it saw a -8.7% change. Historically, ABT's stock price tends to shift by an average of 4.02% in the 10 days leading up to earnings and 1.76% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate ABT's annual revenue to reach 11.96B, while the EPS is projected at 1.38. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ABT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ABT's stock price typically moves by 4.02% in the 10 days before its earnings and 1.76% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 1.38 and revenue of 11.96B.

The earnings call shows strong growth in key segments like Electrophysiology and Heart Failure, supported by product innovations and international expansion. Despite some challenges in CGM and Nutrition, the company has a diversified portfolio and strategic plans for growth. The Q&A reveals a cautious but optimistic outlook, with management addressing concerns and highlighting opportunities in underpenetrated markets. Overall, the positive growth drivers and strategic focus outweigh the conservative guidance, leading to a positive sentiment.